These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33782643)

  • 1. Gallbladder cancer detected by elevated serum KL-6 levels during the follow-up of interstitial pneumonia: a case report.
    Yonenaga Y; Kurosawa M; Higashide S
    Int Cancer Conf J; 2021 Apr; 10(2):119-126. PubMed ID: 33782643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of colon cancer by increased serum level of Krebs von den Lungen-6 in a patient with dermatomyositis-associated interstitial pneumonia.
    Fukuhara N; Tanino Y; Sato S; Fukuhara A; Uematsu M; Nikaido T; Misa K; Sato Y; Saito J; Wang X; Munakata M
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):265-70. PubMed ID: 26422573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-interleukin-17 biologics on Krebs von den Lungen-6 level in patients with psoriasis.
    Hara H; Miyagawa H; Araya J; Minagawa S; Numata T; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
    J Dermatol; 2021 Jun; 48(6):886-893. PubMed ID: 33860559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
    Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
    Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical Analysis of Krebs von den Lungen-6 (KL-6) Expression in Lung Tissue in Primary Lung Cancer Patients with High Serum KL-6 Levels].
    Yatsuyanagi E; Sato K; Sato K
    Kyobu Geka; 2015 Sep; 68(10):815-9. PubMed ID: 26329623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Krebs von den Lungen-6 as a predictor of relapse in interstitial pneumonia with anti-aminoacyl tRNA synthetase antibodies-positive dermatomyositis.
    Isoda K; Kotani T; Takeuchi T; Konma J; Ishida T; Hata K; Otani K; Fujiwara H; Shoda T; Makino S; Arawaka S
    Clin Respir J; 2018 Jul; 12(7):2235-2241. PubMed ID: 29633527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
    Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
    Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
    Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N
    Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical and Clinical Performance of the Nanopia Krebs von den Lungen 6 Assay in Korean Patients With Interstitial Lung Diseases.
    Cho EJ; Park KJ; Ko DH; Koo HJ; Lee SM; Song JW; Lee W; Lee HK; Do KH; Chun S; Min WK
    Ann Lab Med; 2019 May; 39(3):245-251. PubMed ID: 30623616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease.
    Ko UW; Cho EJ; Oh HB; Koo HJ; Do KH; Song JW
    PLoS One; 2020; 15(12):e0244114. PubMed ID: 33332430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
    Ma H; Lu J; Song Y; Wang H; Yin S
    BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren's syndrome: a case report].
    Yu JF; Jin YB; He J; An Y; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):910-914. PubMed ID: 29045979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.
    Nobashi T; Kubo T; Nakamoto Y; Handa T; Koyasu S; Ishimori T; Mishima M; Togashi K
    J Nucl Med; 2016 Dec; 57(12):1899-1904. PubMed ID: 27339874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapidly progressive organizing pneumonia associated with COVID-19.
    Horii H; Kamada K; Nakakubo S; Yamashita Y; Nakamura J; Nasuhara Y; Konno S
    Respir Med Case Rep; 2020; 31():101295. PubMed ID: 33224726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia.
    Kattner S; Sutharsan S; Berger MM; Limmer A; Jehn LB; Herbstreit F; Brenner T; Taube C; Bonella F
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.
    Sato S; Kato T; Abe K; Hanaoka T; Yano Y; Kurosaki A; Yasuda M; Sekino T; Fujiwara K; Hasegawa K
    Oncol Lett; 2017 Jul; 14(1):776-786. PubMed ID: 28693233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab.
    Ono T; Iwasaki T; Terada Y; Abe K; Lee J; Mochizuki M; Miyata K
    Am J Ophthalmol Case Rep; 2020 Jun; 18():100660. PubMed ID: 32215341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.